Showing results (1801-1810 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|October 1, 2025
Evaluation of the anti-leukemia activity and underlying mechanisms of the novel perinucleolar compartment inhibitor CTI-2 in acute myeloid leukemiaAnran Li, Mingmin Yu, Yue Zhao, et al.Investigational New Drugs|September 12, 2025
Comparative analysis of the effects of PSPH and PHGDH inhibitors on tumor cell proliferationYanbing Wang, Longze ShaInvestigational New Drugs|February 6, 2026
The mechanistic role of Wilms tumor 1-associated protein in cancer pathogenesis, immunity, immunotherapy, and therapy resistanceSarah Qutayba Badraldin, Karar H Alfarttoosi, Hayder Naji Sameer, et al.Investigational New Drugs|January 26, 2026
Design, synthesis, anticancer activity, bioimaging, and molecular docking of novel fluorescent isatin derivativesMerve İnel, Ayse Yildirim, Mustafa Yilmaz, et al.Investigational New Drugs|July 31, 2025
Pharmacokinetics, efficacy and safety of palbociclib and fulvestrant in a patient with hormone receptor-positive, human epidermal growth factor receptor 2 negative metastatic breast cancer with end-stage renal disease undergoing hemodialysis: A case reportToshiaki Takakura, Tsutomu Iwasa, Chiyo K Imamura, et al.Investigational New Drugs|April 24, 2025
PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancerSusy Shim, Anke Reinacher-Schick, Anna-Lena Kraeft, et al.Investigational New Drugs|April 30, 2025
Retrospective analysis of clinical features of pembrolizumab induced psoriasisMing Shu, Zhiqiang Fan, Bin Huang, et al.Investigational New Drugs|April 30, 2025
Navigating antibody‒drug conjugates (ADCs): from metastatic to early breast cancer treatment strategiesTala Najdi, Lea Awad, Antoine Chartouni, et al.Investigational New Drugs|March 27, 2025
Rare exon 18 G719A and exon 21 L833V compound EGFR mutations show favorable response to Third-Generation TKI Furmonertinib: A case report and literature reviewYuejian, Jijun Zhao, Tao Wu, et al.Investigational New Drugs|March 7, 2026
Prognostic factors and outcome measures after BRAF-directed targeted therapy of unresectable metastatic BRAFV600E colorectal cancer: a study cohort-level analysisGiuseppe A Colloca, Antonella VenturinoPageof 372